Enlivex Therapeutics Ltd. Operating Expenses | ENLV

Annual Operating Expenses Enlivex Therapeutics Ltd.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
15 M	15.9 M	29.4 M	25.8 M	19.3 M	-	8.62 M	5.3 M	5.96 M	15.9 M	15.5 M	7.08 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
29.4 M	5.3 M	14.9 M

Quarterly Operating Expenses Enlivex Therapeutics Ltd.

2025-Q4	2025-Q2	2024-Q4	2024-Q2	2023-Q4	2023-Q2	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
15 M	3.08 M	15.9 M	2.99 M	29.4 M	6.65 M	-	-	-	-	-	-	3.81 M	-	-	-	2.23 M	-	-	-	1.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
29.4 M	1.3 M	8.93 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
AbbVie ABBV	12.8 B	$ 263.04	0.49 %	$ 465 B	USA
AbCellera Biologics ABCL	292 M	$ 11.41	2.15 %	$ 3.41 B	Canada
Фармсинтез LIFE	201 M	-	-	-	Russia
Aclaris Therapeutics ACRS	92.7 M	$ 5.53	6.02 %	$ 678 M	USA
ADC Therapeutics SA ADCT	334 M	$ 1.09	3.74 %	$ 139 M	Schweiz
Amryt Pharma plc AMYT	109 M	-	-	$ 621 M	Britain
Evelo Biosciences EVLO	108 M	-	-14.46 %	$ 27.9 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Clovis Oncology CLVS	88.7 M	-	-7.23 %	$ 13 M	USA
Chimerix CMRX	96.8 M	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	110 M	-	-	$ 401 M	USA
ADMA Biologics ADMA	101 M	$ 8.61	0.16 %	$ 2.05 B	USA
Eiger BioPharmaceuticals EIGR	62.1 M	-	-9.21 %	$ 2.55 M	USA
89bio ETNB	385 M	-	-	$ 1.55 B	USA
Freeline Therapeutics Holdings plc FRLN	98.4 M	-	-	$ 384 M	Britain
Fusion Pharmaceuticals FUSN	101 M	-	-	$ 1.41 B	Canada
Guardion Health Sciences GHSI	9.73 M	-	-0.31 %	$ 3.64 M	USA
Genocea Biosciences GNCA	53.7 M	-	-15.0 %	$ 3.04 M	USA
Gritstone Oncology GRTS	156 M	-	0.42 %	$ 213 M	USA
G1 Therapeutics GTHX	122 M	-	-	$ 370 M	USA
Harpoon Therapeutics HARP	100 M	-	-	$ 763 M	USA
Humanigen HGEN	70.8 M	-	-81.12 %	$ 4.28 M	USA
HOOKIPA Pharma HOOK	56.3 M	-	-6.92 %	$ 79.4 M	USA
Intercept Pharmaceuticals ICPT	560 M	-	-	$ 643 M	USA
IGM Biosciences IGMS	211 M	-	-	$ 76.9 M	USA
IMV IMV	35.1 M	-	-	$ 13.1 M	Canada
Intra-Cellular Therapies ITCI	228 M	-	-	$ 13.6 B	USA
Kinnate Biopharma KNTE	121 M	-	-	$ 123 M	USA
Chinook Therapeutics KDNY	57.1 M	-	-	$ 2.6 B	USA
Kaleido Biosciences KLDO	88.8 M	-	-3.69 %	$ 12.4 M	USA
Kronos Bio KRON	103 M	-	1.49 %	$ 50.8 M	USA
Karuna Therapeutics KRTX	495 M	-	-	$ 12.2 B	USA
Landos Biopharma LABP	22.7 M	-	0.58 %	$ 144 M	USA
La Jolla Pharmaceutical Company LJPC	61.4 M	-	-	$ 154 M	USA
LogicBio Therapeutics LOGC	44.4 M	-	-	$ 229 M	USA
Lumos Pharma LUMO	38.7 M	-	-	$ 35.3 M	USA
Merrimack Pharmaceuticals MACK	2.04 M	-	-	$ 216 M	USA
Stealth BioTherapeutics Corp MITO	46.3 M	-	-	$ 23.9 M	USA
Mirati Therapeutics MRTX	772 M	-	-	$ 3.3 B	USA
NexImmune NEXI	33 M	-	70.13 %	$ 4.12 M	USA
9 Meters Biopharma NMTR	42 M	-	-42.97 %	$ 1.05 M	USA
InVivo Therapeutics Holdings Corp. NVIV	10.6 M	-	-37.48 %	$ 476 K	USA
Nymox Pharmaceutical Corporation NYMX	11.7 M	-	-19.68 %	$ 18.4 M	Canada
ObsEva SA OBSV	74.6 M	-	-15.52 %	$ 10.5 M	Schweiz
Oncorus ONCR	76.5 M	-	-8.54 %	$ 3.19 M	USA
OncoSec Medical Incorporated ONCS	43.4 M	-	31.87 %	$ 1.61 M	USA
Oncternal Therapeutics ONCT	42.5 M	-	-24.12 %	$ 1.56 M	USA
Opiant Pharmaceuticals OPNT	42.6 M	-	-	$ 109 M	USA
Orchard Therapeutics plc ORTX	159 M	-	1.02 %	$ 90.8 M	Britain